BioNTech SE (BNTX) Interest Coverage Ratio Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 751.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 751.68% |
| Sep 30, 2025 | 241.80% |
| Jun 30, 2025 | -45.91% |
| Mar 31, 2025 | -85.40% |
| Dec 31, 2024 | 43.52% |
| Sep 30, 2024 | 96.41% |
| Jun 30, 2024 | -69.45% |
| Mar 31, 2024 | 578.23% |
| Dec 31, 2023 | -0.89% |
| Sep 30, 2023 | 93.42% |
| Jun 30, 2023 | 213.74% |
| Mar 31, 2023 | 96.82% |
| Dec 31, 2022 | 99.08% |
| Sep 30, 2022 | -872.11% |
| Jun 30, 2022 | -1,496.13% |
| Mar 31, 2022 | -100.00% |
| Dec 31, 2021 | -100.00% |
| Mar 31, 2021 | 6,270,672.74% |
| Dec 31, 2020 | 12,930,899,071,007.89% |
| Dec 31, 2019 | -3,184.72% |
| Sep 30, 2019 | -2,472,018,948.50% |